Eledon Pharmaceuticals (ELDN) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.24% |
| Dec 31, 2025 | 22.12% |
| Sep 30, 2025 | -4.61% |
| Jun 30, 2025 | -2.16% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | 1.32% |
| Sep 30, 2024 | -13.52% |
| Jun 30, 2024 | -13.21% |
| Mar 31, 2024 | -25.01% |
| Dec 31, 2023 | -23.27% |
| Sep 30, 2023 | -20.69% |
| Jun 30, 2023 | 116.65% |
| Mar 31, 2023 | 81.70% |
| Dec 31, 2022 | 103.99% |
| Sep 30, 2022 | 114.21% |
| Jun 30, 2022 | 104.03% |
| Mar 31, 2022 | 128.93% |
| Dec 31, 2021 | 115.56% |
| Sep 30, 2021 | 107.16% |
| Jun 30, 2021 | 100.21% |
| Mar 31, 2021 | 94.83% |
| Dec 31, 2020 | 111.33% |
| Sep 30, 2020 | 103.01% |
| Jun 30, 2020 | -26.86% |
| Mar 31, 2020 | -19.02% |
| Dec 31, 2019 | 109.08% |
| Sep 30, 2019 | -25.44% |
| Jun 30, 2019 | -27.02% |
| Mar 31, 2019 | -38.46% |
| Dec 31, 2018 | -36.96% |
| Sep 30, 2018 | -36.44% |
| Jun 30, 2018 | -35.95% |
| Mar 31, 2018 | -35.51% |
| Dec 31, 2017 | -42.12% |
| Sep 30, 2017 | -40.08% |
| Dec 31, 2016 | -66.66% |